Clovis Oncology, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-10-11: Reporting owner Fair Richard A.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-10-11: Reporting owner Flaherty Keith T.; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-10-11: Reporting owner SPICKSCHEN THORLEF; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-10-11: Reporting owner ATWOOD BRIAN G; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-10-11 | Fair Richard A. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,848 25,848 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-10-11 | Flaherty Keith T. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,770 14,770 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-10-11 | SPICKSCHEN THORLEF Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,770 14,770 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-10-11 | ATWOOD BRIAN G Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,770 14,770 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-10-11 | GRAHAM GINGER L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,770 14,770 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-10-11 | KLINGENSTEIN PAUL H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,770 14,770 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-10-11 | Azelby Robert Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,848 25,848 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-10-11 | McKinley Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,770 14,770 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-10-11 | BARRETT M JAMES Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,770 14,770 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-10-11 | BLAIR JAMES C Director | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,770 14,770 owned after | $27.92 exercise price | 2018-10-15 | |
| 2018-03-01 | Hooks Corwin Dale Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $58.43 exercise price | 2018-03-02 | |
| 2018-03-01 | MUEHL DANIEL W Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $58.43 exercise price | 2018-03-02 | |
| 2018-03-01 | IVERS-READ GILLIAN C Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,000 11,000 owned after | $58.43 exercise price | 2018-03-02 | |
| 2018-03-01 | MAHAFFY PATRICK J Director, Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +120,000 120,000 owned after | $58.43 exercise price | 2018-03-02 | |
| 2018-03-01 | Rolfe Lindsey Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,000 11,000 owned after | $58.43 exercise price | 2018-03-02 |